Evidence map›Paper›PMID 42109637›Full record

ArticleApplied sciences (Basel, Switzerland)2026

Engineering Brain Injury In Vitro: Human iPSC-Based Organoids in Microfluidic Systems.

Satarupa Jena, Samuel Uzoechi, Cody Badeaux, Charity Johnson Campbell, Hailey Egido-Betancourt, Hala Madi, John Collins, Chioma Okey-Mbata, Qassim Dirar, Doo Yeon Kim and 6 more

Abstract read
In one paragraph

Article in Applied sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Satarupa JenaNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
Samuel UzoechiNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.ORCID 0000-0003-2438-0143
Cody BadeauxNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
Charity Johnson CampbellNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
Hailey Egido-BetancourtNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.ORCID 0000-0002-6579-2411
Hala MadiNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
John CollinsBiopico Systems Inc., 188 Technology Dr, Suite G, Irvine, CA 92618, USA.ORCID 0000-0003-3238-0987
Chioma Okey-MbataNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.ORCID 0009-0001-8942-6571
Qassim DirarQorvo Inc., 7907 Piedmont Triad Pkwy, Greensboro, NC 27409, USA.
Doo Yeon KimGenetics and Aging Research Unit, Mass General Hospital, Harvard Medical School, 114 16th Street, Charlestown, MA 02129, USA.ORCID 0000-0002-6969-0340
Sang Su KwakGenetics and Aging Research Unit, Mass General Hospital, Harvard Medical School, 114 16th Street, Charlestown, MA 02129, USA.
Sangho YeDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Salil DesaiIndustrial Engineering Department, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.ORCID 0000-0002-6116-2105
Jin-Moo LeeDepartment of Neurology, Washington University in St. Louis, St. Louis, MO 63110, USA.
Daniel LaskowitzDepartment of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
Yeoheung YunNERVE Center, FIT BEST Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.

Funding

Studying the pathogenic roles of human CD8+ T cells in Alzheimer's disease using a 3D human Peripheral immune Chip.R01AG082328 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Mehdi Jorfi, Doo Yeon Kim · 2024 to 2026
$2.0M
Alzheimer's disease-replicated brain microphysiological system to model AD physiopathology and its influenceon gliovasculature and immune systemSC1NS122448 · NINDS · NORTH CAROLINA AGRI & TECH ST UNIV · PI YUN, YEOHEUNG · 2021 to 2024
$1.4M
Center for Neurovascular Engineering Research and adVanced Education (NERVE)UG3EB036466 · NIBIB · NORTH CAROLINA AGRI & TECH ST UNIV · PI Yeoheung Yun · 2024 to 2026
$1.2M
NIA NIH HHS R01 AG082328NIBIB NIH HHS UG3 EB036466NINDS NIH HHS SC1 NS122448
6 · The paper itself

Abstract

Traumatic brain injury (TBI) presents a major biomedical challenge due to its complex biomechanics and the heterogeneous cellular responses it elicits, including neuronal death, glial activation, and blood-brain barrier disruption. Traditional in vitro models, including 2D neuronal cultures, brain slices and transwell systems, have provided valuable insights into molecular and cellular biology but remain limited by their lack of human-specific architecture, vascularization, and neurovascular interactions. The purpose of this review is to systematically examine advances in in vitro TBI modeling, with particular attention to studies leveraging human induced pluripotent stem cell (iPSC)-derived neural and vascular tissues, organoids, hydrogel scaffolds, microfluidic platforms, and mechanical injury. We highlight how the integration of neurovascular unit (NVU) components has improved the physiological and functional relevance of these models. Finally, we identify key limitations, including variability in organoid maturation, incomplete vascularization, and lack of methodological standardization, and outline future directions for improving translational fidelity. Therefore, this review contributes to a critical evaluation of emerging technologies and their potential to advance neurotrauma research and therapeutic discovery.

Indexed as

drug discoveryhuman induced pluripotent stem cellsmicrofluidicsneurovascular unitstraumatic brain injury

Identifiers

PMID42109637
PMCPMC13152003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.